10 Jan 2025
Modi-1 successfully achieved Simon stage 1 suggesting the combination of Modi-1 and checkpoint blockade is beneficial in HPV negative head and neck squamous cell carcinoma (SCCHN)
This result supports the continuation of the study in this indication Moditope® patent granted by U.S. Patent and Trademark Office (USPTO)
Scancell, a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has achieved significant... Read more
